MedPark Pharmacy
FDA inspection history in Annapolis, Maryland, 2018 to 2020
- 2
- Form 483s
- 1
- Close-out
Every document, by year
- Form 483
- Close-out
2018: one close-out letter; 2020: two Form 483s.
The story so far
Built from the dates and citations on the documents themselves.
- 2018–20Two Form 483s and one close-out letter, at Annapolis, Maryland.
- 2020The longest 483 on file: 5 observations over 3 pages at Annapolis, Maryland.
Cited most
Across all MedPark Pharmacy observations on file
- 21 CFR 211.113Control of microbiological contamination3
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.167Special testing requirements1
- 21 CFR 211.65Equipment construction1
The complete MedPark Pharmacy file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Annapolis, Maryland
Two Form 483s and one close-out letter · 2018 to 2020 · 9 observations
Latest: Form 483, May 23, 2020 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-05-23 | 483 Form 483 | Annapolis, Maryland | 5 | $99 |
| 2020-03-09 | 483 Form 483 | Annapolis, Maryland | 4 | $99 |
| 2018-03-05 | Close-out Close-out letter | Annapolis, Maryland | — | $99 |
Investigators on these documents
FEI number 3012299349 · most recent document May 23, 2020
About MedPark Pharmacy
How many FDA Form 483s has MedPark Pharmacy received?
FDA Intel has 2 Form 483s on file for MedPark Pharmacy; the most recent is dated May 23, 2020.
When was MedPark Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for MedPark Pharmacy is a Form 483 dated May 23, 2020, for the site in Annapolis, Maryland.
What did FDA cite at MedPark Pharmacy?
The regulations cited most in the observations on file for MedPark Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.42 (Design and construction features), 2 times; 21 CFR 211.165 (Testing and release for distribution), 1 time.